In this regard, a selective chemical inhibitor of PGC1α identified in a chemical screen has been shown to improve type 2 diabetes by increasing the acetylation and consequently reducing the HNF4/PGC1α gluconeogenic transcription program [26]. This evidence concerns the gene PPARGC1A and type 2 diabetes mellitus.